rs200864382

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_004667.6(HERC2):​c.4651A>C​(p.Ile1551Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00056 in 1,611,812 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00057 ( 1 hom. )

Consequence

HERC2
NM_004667.6 missense

Scores

1
3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 7.61

Publications

0 publications found
Variant links:
Genes affected
HERC2 (HGNC:4868): (HECT and RLD domain containing E3 ubiquitin protein ligase 2) This gene belongs to the HERC gene family that encodes a group of unusually large proteins, which contain multiple structural domains. All members have at least 1 copy of an N-terminal region showing homology to the cell cycle regulator RCC1 and a C-terminal HECT (homologous to E6-AP C terminus) domain found in a number of E3 ubiquitin protein ligases. Genetic variations in this gene are associated with skin/hair/eye pigmentation variability. Multiple pseudogenes of this gene are located on chromosomes 15 and 16. [provided by RefSeq, Mar 2012]
HERC2 Gene-Disease associations (from GenCC):
  • developmental delay with autism spectrum disorder and gait instability
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17886126).
BP6
Variant 15-28233170-T-G is Benign according to our data. Variant chr15-28233170-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 518259.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HERC2NM_004667.6 linkc.4651A>C p.Ile1551Leu missense_variant Exon 30 of 93 ENST00000261609.13 NP_004658.3 O95714A8KAQ8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HERC2ENST00000261609.13 linkc.4651A>C p.Ile1551Leu missense_variant Exon 30 of 93 1 NM_004667.6 ENSP00000261609.8 O95714

Frequencies

GnomAD3 genomes
AF:
0.000427
AC:
65
AN:
152242
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000723
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000794
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000391
AC:
98
AN:
250874
AF XY:
0.000354
show subpopulations
Gnomad AFR exome
AF:
0.0000622
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000554
Gnomad NFE exome
AF:
0.000697
Gnomad OTH exome
AF:
0.000491
GnomAD4 exome
AF:
0.000574
AC:
837
AN:
1459452
Hom.:
1
Cov.:
30
AF XY:
0.000550
AC XY:
399
AN XY:
726058
show subpopulations
African (AFR)
AF:
0.0000901
AC:
3
AN:
33298
American (AMR)
AF:
0.00
AC:
0
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
86156
European-Finnish (FIN)
AF:
0.000505
AC:
27
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.000692
AC:
769
AN:
1111706
Other (OTH)
AF:
0.000332
AC:
20
AN:
60200
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
43
86
128
171
214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000427
AC:
65
AN:
152360
Hom.:
0
Cov.:
31
AF XY:
0.000376
AC XY:
28
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.0000721
AC:
3
AN:
41596
American (AMR)
AF:
0.00
AC:
0
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000794
AC:
54
AN:
68044
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000629
Hom.:
0
Bravo
AF:
0.000382
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000436
AC:
53
EpiCase
AF:
0.000491
EpiControl
AF:
0.000711

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 03, 2022
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Mar 01, 2021
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES Uncertain:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Apr 01, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.4651A>C (p.I1551L) alteration is located in exon 30 (coding exon 29) of the HERC2 gene. This alteration results from a A to C substitution at nucleotide position 4651, causing the isoleucine (I) at amino acid position 1551 to be replaced by a leucine (L). The p.I1551L alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
21
DANN
Benign
0.96
DEOGEN2
Benign
0.075
T
Eigen
Benign
0.16
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.0063
T
MetaRNN
Benign
0.18
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
7.6
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-0.83
N
REVEL
Benign
0.13
Sift
Benign
0.39
T
Polyphen
0.52
P
Vest4
0.56
MVP
0.45
MPC
0.77
ClinPred
0.074
T
GERP RS
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.13
gMVP
0.46
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200864382; hg19: chr15-28478316; API